WPI 2233 (Tamoxifen 20 mg)
Pill imprint WPI 2233 has been identified as Tamoxifen citrate 20 mg.
Tamoxifen is used in the treatment of breast cancer; breast cancer, metastatic; breast cancer, adjuvant; breast cancer, prevention; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 2233 (Tamoxifen 20 mg)
- 20 mg
- Prescription only
- Drug Class:
Selective estrogen receptor modulators
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
pregelatinized corn starch
More about tamoxifen
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...